Discovery of Imigliptin, a Novel Selective DPP-4 Inhibitor for the Treatment of Type 2 Diabetes-Reference-Cited by-同舟云学术

Discovery of Imigliptin, a Novel Selective DPP-4 Inhibitor for the Treatment of Type 2 Diabetes

Published:2014-06-16 Issue:8 Volume:5 Page:921-926
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Shu Chutian¹,Ge Hu²,Song Michael¹,Chen Jyun-hong¹,Zhou Huimin¹,Qi Qu¹,Wang Feng¹,Ma Xifeng¹,Yang Xiaolei¹,Zhang Genyan¹,Ding Yanwei¹,Zhou Dapeng¹,Peng Peng¹,Shih Cheng-kon¹²,Xu Jun²,Wu Frank¹²

Affiliation:

1. Department of Project Management, Medicinal Chemistry, Process, Pharmacology, Drug Metabolism and Pharmacokenetics, Toxicology, XuanZhu Pharma, 2518 Tianchen Street, Jinan, Shandong, The People’s Republic of China

2. School of Pharmaceutical Sciences & Institute of Human Virology, Sun Yat-Sen University, 132 East Circle Road at University City, Guangzhou, The People’s Republic of China

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ml5001905

Reference9 articles.

1. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants

2. Globalization of Diabetes

3. Dipeptidyl peptidase IV (DPP IV) and related molecules in type 2 diabetes

4. Dipeptidyl Peptidase IV and Its Inhibitors: Therapeutics for Type 2 Diabetes and What Else?

5. Profound Methyl Effects in Drug Discovery and a Call for New CH Methylation Reactions

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current trends and future directions for the synthesis and pharmacological applications of 2-(2-cyanopyrrolidin-1-yl)-N-3-hydroxyadamantan-1-yl) acetamide (Gliptins);Medicinal Chemistry Research;2024-06-11

2. Anwendung von Organometallkatalysatoren in der API-Synthese;Organometallik in der Prozesschemie;2024

3. Development of Long-Acting Dipeptidyl Peptidase-4 Inhibitors: Structural Evolution and Long-Acting Determinants;Journal of Medicinal Chemistry;2023-08-30

4. Insight into Structure Activity Relationship of DPP-4 Inhibitors for Development of Antidiabetic Agents;Molecules;2023-08-03

5. Design, synthesis, in vitro anti-oxidant evaluation, α-amylase inhibition assay, and molecular docking analysis of 2-(2-benzylidenehydrazinyl)-4,4-diphenyl-1H-imidazol-5(4H)-ones;Journal of Molecular Structure;2023-04